Zhang Cuimiao, Liu Yamin, Wang Jianyuan, Ge Kun, Wei Wan, Jia Guang, Shen Shigang
J Nanosci Nanotechnol. 2017 Jan;17(1):153-60. doi: 10.1166/jnn.2017.12458.
Monodisperse mesoporous silica nanospheres with novel self-activated luminescence have been fabricated by a modified templating sol–gel method followed by heat treatment, without introducing any rare earth or transition metal ions as activators. The SEM, TEM, and N2 adsorption/desorption isotherms results show that the as-obtained mesoporous silica nanospheres exhibit well-defined morphology, good dispersion, high specific surface area and pore volume. MTT assay indicates that the sample exhibits no obvious cytotoxicity against the A549, HeLa, and MCF-7 cells, which make it suitable to be utilized as a drug carrier. Under ultraviolet excitation, the sample exhibits an intense blue emission. Interestingly, the photoluminescence intensity of the IBU drug loaded system increases with the increase of cumulatively released IBU. Due to the relationship between the luminescence properties and drug release behavior, the as-obtained luminescent drug carrier may be potential as a probe for monitoring or detecting the drug release process.
通过改进的模板溶胶-凝胶法并结合热处理,制备出了具有新型自激活发光特性的单分散介孔二氧化硅纳米球,且未引入任何稀土或过渡金属离子作为激活剂。扫描电子显微镜(SEM)、透射电子显微镜(TEM)和N₂吸附/脱附等温线结果表明,所制备的介孔二氧化硅纳米球具有明确的形态、良好的分散性、高比表面积和孔体积。噻唑蓝(MTT)检测表明,该样品对A549、HeLa和MCF-7细胞无明显细胞毒性,这使其适合用作药物载体。在紫外光激发下,该样品呈现强烈的蓝色发射。有趣的是,负载布洛芬(IBU)药物的体系的光致发光强度随着累积释放的IBU的增加而增强。由于发光特性与药物释放行为之间的关系,所制备的发光药物载体有望作为监测或检测药物释放过程的探针。